Table 1.
Correlations between SNHG7 expression and clinicopathological characteristics in gastric cancer patients.
| Characteristics | n | High expression(%) | Low expression(%) | P |
|---|---|---|---|---|
| Gender | ||||
| Female | 60 | 34(56.7) | 26(43.3) | 0.193 |
| Male | 102 | 47(46.1) | 55(53.9) | |
| Age(y) | ||||
| <50 | 64 | 31(48.4) | 33(51.6) | 0.748 |
| ≥50 | 98 | 50(51.0) | 48(49.0) | |
| Lauren’s classification | ||||
| Intestinal | 90 | 39(43.3) | 51(56.7) | 0.058 |
| Diffuse | 72 | 42(58.3) | 30(41.7) | |
| TMN stage | ||||
| I-II | 59 | 22(37.3) | 37(62.7) | 0.014 |
| III-IV | 103 | 59(57.3) | 44(42.7) | |
| Depth of invasion | ||||
| T1-T2 | 68 | 24(35.3) | 44(64.7) | 0.001 |
| T3-T4 | 94 | 57(60.6) | 37(39.4) | |
| Lymph node metastasis | ||||
| N0-N1 | 70 | 26(37.1) | 44(62.9) | 0.004 |
| N2-N3 | 92 | 55(59.8) | 37(40.2) | |
| Distant metastasis | ||||
| M0 | 148 | 67(45.3) | 81(54.7) | <0.001 |
| M1 | 14 | 14(100) | 0(0) |